Navigation Links
Arobella Medical Achieves ISO 13485 Medical Device Certification
Date:2/3/2009

MINNEAPOLIS, Feb. 3 /PRNewswire/ -- Arobella Medical, LLC, today announced the achievement of ISO 13485:2003 certification for the design, development, manufacturing, test, and delivery of medical devices. This certification, developed by the International Organization for Standardization (ISO), is the regulatory standard for the international medical industry and is closely related to ISO 9000 and EN 46000. Receiving the certification proves that the design, development and manufacturing functions at Arobella Medical meet the highest quality internationally recognized standards known for medical devices. Arobella Medical was assessed and registered by Intertek Testing Services NA Ltd.

Arobella Medical produces the Qoustic Wound Therapy System(TM), an FDA-cleared wound therapy device that applies low-frequency, cavitational ultrasound to gently remove dead and diseased tissue cells, kill harmful bacteria and biofilm, and leave healthy and pre-healing granulation tissue intact. Already on sale in the United States, ISO 13485 certification brings the device one step closer to a wider international marketplace. ISO 13485 is a regulatory requirement in a number of international markets for the manufacture of medical devices, including Europe, Canada, Taiwan and Australia, and forms the cornerstone for the CE certification of medical products in the EU.

"This certification demonstrates our continued commitment to developing the finest, cutting-edge ultrasound medical devices on the market," said Eliaz Babaev, PhD, president and CEO of Arobella Medical. "We continually strive to be the best in ultrasound, and have the data to prove it. We will use this achievement to bring our products to the rest of the world."

About Arobella Medical, LLC

Arobella Medical, LLC is Minneapolis-based medical device company specializing in low-frequency ultrasound in wound management therapies. Arobella Medical, LLC is positioned to become the leader in advanced ultrasound wound care technologies and devices. Arobella Medical, LLC co-founder and CEO Eliaz Babaev has more than 45 years of experience developing, designing and commercializing medical devices that use ultrasound. For more information, go to http://www.arobella.com.

     Contact:

     Glenn Carlson, Business Affairs Manager
     Arobella Medical, LLC,
     +1-612-288-2826,
     gcarlson@arobella.com

'/>"/>
SOURCE Arobella Medical, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arobella Medical CEO Speaks at International Wound Care Conference in Paris
2. MSU engineering team designs innovative medical device
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
5. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
6. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
7. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
8. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
9. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
10. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
11. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to the La Gorce Country Club in Miami Beach to host its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... and uncertainty in clinical trials, today announced that Premier Research, a leading clinical ... solution. , Clinical trials are becoming increasingly complex, due in part to an ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... VALLEY COTTAGE, New York , February 23, 2017 ... to health implications arising from increasing caseload for varicose ... cases recorded across the globe are prompting the adoption ... A latest study on global endovenous laser therapy ... growing attention towards aftereffects of lifestyle choices and consequences ...
Breaking Medicine Technology: